Market Performance - In December 2025, the three major A-share indices showed a fluctuating trend in the early part of the month and strengthened in the latter part, with the Shanghai Composite Index achieving 11 consecutive days of gains [1] - The Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index rose by 2.06%, 4.17%, and 4.93% respectively in December [1] - Commodity futures such as gold, silver, copper, aluminum, and lithium carbonate also experienced strong upward trends in December [1] Private Equity Fund Performance - In this market context, over 51% of the 352 private equity products under a major private equity firm reached historical net value highs last month [2] - Among the products, stock strategy products were the most numerous, with 249 products (225 quantitative long and 8 subjective long), accounting for over 70% [2] - Quantitative products comprised 307 products (with 180 being index-enhanced), making up nearly 90% of the total, while non-quantitative products accounted for only 45 [3] Notable Private Equity Firms - Twelve major private equity firms had all their products (with at least three products displayed on the private equity ranking website) reach historical net value highs last month [4] - The firms ranked by average returns for 2025 include Lingjun Investment, Ningbo Huafang Quantitative, Chengqi Private Equity, and others, with eight firms being quantitative private equity [4][5] - Notably, Ningbo Huafang Quantitative had 10 products (all index-enhanced) with an average return exceeding ***% for 2025, ranking second among quantitative private equity firms [8][9] Performance Rankings - The top five products by average returns for 2025 came from firms such as Yuanshin Investment, Yinye Investment, Longqi Technology, Lingjun Investment, and Pingfang Investment, with two subjective long products taking the top two spots [14] - The threshold for the top 20 products in terms of returns over the past three years was close to ***%, with notable products from Abama Investment and Honghu Private Equity [19][21] - Over the past five years, the top five products were from Honghu Private Equity, Jiukun Investment, Minghuan Investment, Tianyan Capital, and Century Frontier, with a similar threshold for the top 20 products [23][25]

Group 1 - In 2025, the Chinese market showed significant growth, with major stock markets rising sharply and structural opportunities in various sectors, particularly in technology growth stocks, which drove the ChiNext Index up nearly 50% [1] - The period of comprehensive gains for Hong Kong and A-shares was limited to May to September, with declines in other months, notably a drop of over 7% in April due to the "tariff black swan" impact [1] Group 2 - In the private equity market, a subset of products achieved impressive annual returns, with 229 products realizing positive returns for 12 consecutive months in 2025, representing only 4.46% of the total 5139 products [3] - The average cumulative return for these products was 31.83%, with 1006 products from top private equity firms showing performance data, of which 88 had positive returns for 12 months, accounting for 8.75% [3][4] Group 3 - Among the top 20 products with positive returns, 16 were quantitative long products, and 2 were composite strategy products, with 2 products from a hundred billion private equity firm making the list [4] - The product "Square and Peak Zhongzheng 2000 Index Enhanced 21" managed by Square and Investment achieved significant returns, with the highest monthly return in August [6] Group 4 - In the category of private equity firms with assets under 5 billion, only 3.41% of the 4133 products had positive returns for 12 consecutive months, with 141 products achieving this feat [9] - The top 20 products in this category included 13 quantitative long products, with the majority coming from smaller private equity firms [9] Group 5 - The only subjective CTA product to make the list was "Yizu Qinggui Lidong," managed by Yizu Investment, which had a notable cumulative return for 2025 [11] - The product "Hua Nian Jin Qu 2" managed by Hua Nian Private Equity ranked 5th, showcasing strong performance [11] Group 6 - The analysis of excess returns revealed that only 30 out of 802 quantitative long products had positive excess returns for 12 consecutive months, representing 3.74% [12] - The top 10 products in this category were primarily managed by hundred billion private equity firms, with notable performances from firms like Jintong Investment and Ming Stone Fund [12]

Core Viewpoint - The A-share market in October experienced high-level fluctuations, with the Shanghai Composite Index showing relative strength, while the Shenzhen Component Index and the ChiNext Index faced pressure. The performance of large-scale private equity funds, particularly those with over 10 billion yuan in assets, stood out in this environment, demonstrating strong research and risk control capabilities [2][3]. Market Performance - In October, the Shanghai Composite Index rose by 1.85%, while the Shenzhen Component Index and ChiNext Index fell by 1.10% and 1.56%, respectively [2]. - The average return of 5,189 private equity products with performance data was 29.04% from January to October, with a mere 0.03% return in October. In contrast, the 662 products under large private equity funds achieved an average return of 1.10% in October and 30.38% year-to-date [2][3]. Private Equity Fund Performance - The performance of private equity funds categorized by size showed that funds with over 10 billion yuan had the highest returns, with an average of 30.38% from January to October [3]. - The average returns for different fund sizes in October were as follows: - 0-5 billion yuan: -0.11% - 5-10 billion yuan: -0.22% - 10-20 billion yuan: -0.12% - 20-50 billion yuan: 0.04% - 50-100 billion yuan: -0.32% - 100 billion yuan and above: 1.10% [3]. Strategy Performance - Among the strategies, stock strategies and multi-asset strategies performed best, with average returns of 33.65% and 23.17%, respectively, from January to October. The quantitative long strategy had the highest average return at 44.65% [3][4]. - The average returns for various strategies in October were: - Multi-asset strategies: 1.67% - Stock strategies: 1.12% - Quantitative long strategies: 1.10% [4][10]. Top Performing Products - The top-performing products in the stock strategy category achieved an average return of 33.65% year-to-date, with the top three products managed by Yuanxin Investment, Jiuku Investment, and Yinye Investment [5]. - In the quantitative long strategy, the top three products were from Longqi Technology, Evolutionary Theory Asset, and Stable Investment, with an average return of 44.65% year-to-date [10][12]. Notable Fund Managers - Wang Aoye from Yuanxin Investment, with a strong background in media and technology, managed a product that achieved significant returns despite market challenges [8]. - Zhu Xiaokang from Longqi Technology, with extensive experience in quantitative strategies, led a product that ranked first in excess returns [13].

Core Viewpoint - The introduction of the CSI 2000 Index reflects the increasing representation of small and medium-sized companies in the A-share market, showcasing strong long-term performance with a cumulative return of 166.50% since its base date, outperforming major broad-based indices [2][3]. Group 1: Characteristics of the CSI 2000 Index - The CSI 2000 Index uniquely focuses on small and micro-cap stocks, comprising 2000 stocks with smaller market capitalizations and better liquidity, effectively complementing other indices like CSI 300 and CSI 500 [7]. - The index covers 30 primary industries, with high-growth sectors such as machinery, electronics, basic chemicals, and pharmaceuticals accounting for nearly 40% of its composition, indicating a diversified and growth-oriented portfolio [9]. - The index exhibits high elasticity and volatility, making it attractive to investors with a higher risk appetite, especially in a macro environment characterized by loose liquidity [11]. Group 2: Investment Strategies and Opportunities - The CSI 2000 Index is well-suited for quantitative strategies due to its lower analyst coverage, allowing for the identification of undervalued stocks and pricing inefficiencies, which can lead to excess returns [19]. - The high trading activity and turnover rates of the CSI 2000 Index enhance the effectiveness of quantitative trading strategies, enabling better monitoring of market dynamics and execution of trades [18]. - The index's broad selection of constituent stocks provides greater freedom in stock selection, allowing for the application of various alpha factors and reducing exposure risks associated with non-index stocks [17].

Core Viewpoint - The article highlights the increasing popularity of dividend-paying assets in the market, with A-shares expected to distribute over 2.39 trillion yuan in dividends in 2024, setting a new historical record. The focus is on the dividend distribution of private equity funds in 2024, with 23.36% of the analyzed products expected to pay dividends [2][3]. Summary by Category Private Equity Fund Dividend Distribution - Among 3938 private equity products with performance data, 920 are expected to distribute dividends in 2024, representing 23.36% of the total [2]. - The leading private equity firm in terms of the number of dividend-paying products is Junfu Investment, with 17 products expected to pay dividends in 2024 [2][3]. Performance of Dividend-Paying Products - Continuous dividends indicate strong profit-generating capabilities, with only 14 products having paid dividends for five consecutive years, showcasing impressive performance [4]. - The average return for private equity products that will distribute dividends in 2024 varies by fund size, with notable performances in different categories [6][12][15]. Performance by Fund Size - **100 Billion+ Yuan Private Equity**: 13.75% of products are expected to pay dividends, with an average return of 21.05% for these products [6][7]. - **50-100 Billion Yuan Private Equity**: 16.17% of products are expected to pay dividends, with an average return of 15.33% [10]. - **20-50 Billion Yuan Private Equity**: 35.96% of products are expected to pay dividends, with an average return of 18.22% [12][13]. - **10-20 Billion Yuan Private Equity**: 24.46% of products are expected to pay dividends, with an average return of 21.66% [15][16]. - **5-10 Billion Yuan Private Equity**: 26.83% of products are expected to pay dividends, with an average return of 20.03% [19][20]. - **0-5 Billion Yuan Private Equity**: 25.39% of products are expected to pay dividends, with an average return of 25.58% [22]. Notable Products and Managers - Junfu Investment's "Junfu Gold Enhanced No. 2" achieved a return of ***% in 2024 and paid dividends twice, leading in the 20-50 billion yuan category [12][14]. - The top-performing product in the 100 billion+ category is "Yanfeng Exclusive Small Cap Index Enhanced No. 1" from Yanfeng Investment, with a return of ***% [8][9]. - In the 50-100 billion category, "Square and Ding Sheng Zhong Zheng 2000 Index Enhanced No. 21A" from Square and Investment paid dividends twice and achieved a return of ***% [10][11].